Innovation Archives | Page 4 of 21

A Note From Our Chair: Post Summit Recap

As our Spring 2024 Digital Health Summit concludes, I am eager to share some of the standout moments with you. For three action-packed days (May 6-8), over 65 healthcare leaders from around the world gathered at the Microsoft Tech Center in NYC to explore the current state and future prospects of digital health.

HITLAB Announces Winners of Spring 2024 Breakthrough Alliance Challenge

New York, NY May 7, 2024 -- HITLAB announced the winners of the Spring 2024 Breakthrough Alliance (BTA) Innovator’s challenge. The BTA is a digital health consortium founded in partnership with New York City Economic Development Corporation and was created to accelerate the optimal adoption of digital health innovations through shared evidence, communication, and perspectives to improve health outcomes, access and care delivery.

Information Mediary Corp Collaborates with Adherence to Launch New Solution

Information Mediary Corp (IMC) announced today, the first day of the HITLAB Spring 2024 Innovator's Summit, that they along with a company called Adherence, have launched a new product that digitizes the Morisky Medication Adherence Scale (MMAS) resulting in better patient care and outcomes.

HITLAB Announces Finalists for Spring 2024 Breakthrough Alliance Challenge

New York, NY – April 29, 2024--Today HITLAB announced the five finalists selected for the Spring 2024 Breakthrough Alliance (BTA) Innovator’s challenge. The BTA is a digital health consortium which was created to accelerate a greater number of innovations to improve health outcomes and care delivery through verified emerging technologies.

HITLAB Expands Breakthrough Alliance Board to Europe

HITLAB, a leading digital health innovation and teaching lab, is happy to announce the expansion of its Breakthrough Alliance (BTA) Board to Europe. The Board European counterpart will be Chaired by Laurent van Lerberghe, Investor Digital Health at Ballas Invest.

HITLAB Partners with Soliddd to Transform Outcomes for Age-related Macular Degeneration

Age-related macular degeneration (AMD) poses a significant challenge in ophthalmology, one of the primary causes of irreversible vision loss worldwide. It affects about 8.7% of all blind individuals globally, casting a shadow over the lives of millions, especially the elderly. The prevalence of AMD is expected to rise sharply, with projections indicating that nearly 288 million people will be affected by 2040.

Revolutionizing Healthcare Access: Insights from HITLAB’s HelixVM User Study

There is an acute need for innovative solutions in healthcare in this day of extended patient wait times, overworked doctors, and onerous administrative procedures. Data from recent surveys show that Americans wait an average of 26 days to see a healthcare provider, and that providers themselves find it difficult to handle the enormous burden of caring for 2,500 patients, which requires an estimate of 26.7 hours of time each day.

Final Agenda for New York City Health Innovation Week Released

New York City, NY – April 8, 2024 – HITLAB is thrilled to unveil the final agenda for its highly anticipated New York City Health Innovation Week (NYCHIW), scheduled to take place from May 5th-9th, 2024. In addition to the main event, the Innovators Summit, this week-long program will feature a series of 9 smaller events spread across various locations in New York City showcasing the latest advancements and trends in healthcare innovation.

NeuraMetrix: Transforming Neurological Diagnostics with Innovative Digital Biomarkers

The escalating prevalence of neurological disorders presents a growing challenge for healthcare, particularly in an aging population. Early diagnosis is crucial for effective treatment, but the mildness of initial symptoms and the absence of accessible monitoring tools can result in delays. Additionally, existing biomarkers lack objectivity, detailed insights, and reproducibility, impeding progress in diagnosis, treatment, and drug development.